rps138_slide_obat-obat_dalam_masa_kehamilan(2)

download rps138_slide_obat-obat_dalam_masa_kehamilan(2)

of 30

Transcript of rps138_slide_obat-obat_dalam_masa_kehamilan(2)

  • 8/6/2019 rps138_slide_obat-obat_dalam_masa_kehamilan(2)

    1/30

    -

    Tri Widyawati - Datten Bangun

    Departemen Farmakologi & Terapeutik

    2007

  • 8/6/2019 rps138_slide_obat-obat_dalam_masa_kehamilan(2)

    2/30

    -

    oleh ibu hamil dapat melewati plasenta danda at masuk ke tubuh anin

    Efek farmakologi

    e era ogen

  • 8/6/2019 rps138_slide_obat-obat_dalam_masa_kehamilan(2)

    3/30

    PharmacokineticsCritical factors affecting placental drug transfer anddrug effects on fetus :

    1. Physicochemical properties of the drug

    .

    3. The amount of drug reaching the fetus

    .

    5. Distribution characteristic in different fetal

    6. The stage of placental and fetal development at

    7. The effects of drugs used in combination

  • 8/6/2019 rps138_slide_obat-obat_dalam_masa_kehamilan(2)

    4/30

    .1. Li ho hilic dru s :

    - tends to diffuse readily across the placenta- enter the fetal circulation

    Thiopental (used during caesarean section) :

    cross the placenta immediately can produce sedation or apnea in the new

  • 8/6/2019 rps138_slide_obat-obat_dalam_masa_kehamilan(2)

    5/30

    ..

    - cross the placenta slowly achieve lowconcentration in the fetus

    Succinylcholine or tubocurarine

  • 8/6/2019 rps138_slide_obat-obat_dalam_masa_kehamilan(2)

    6/30

    .

    . , - -

    concentration gradient cross the placenta

    Salicylate

  • 8/6/2019 rps138_slide_obat-obat_dalam_masa_kehamilan(2)

    7/30

    B. Molecular SizeDrugs with mol. weight :

    - -

    - 500-1000 : more difficulty- > 1000 : poorly

    Heparin :- very arge an po ar una e to cross t e p acenta

    - safe to the fetus

    - Warfarin : - smaller than heparin

    -

    - should be avoided

  • 8/6/2019 rps138_slide_obat-obat_dalam_masa_kehamilan(2)

    8/30

    .

    -.

    back to the maternal circulation

    - cancer drugs (vinblastin, doxorubicin)- digoxin

  • 8/6/2019 rps138_slide_obat-obat_dalam_masa_kehamilan(2)

    9/30

    .

    ,

    barbiturates, phenytoin, local anaesthetics

    plasma than in fetal plasma because of

  • 8/6/2019 rps138_slide_obat-obat_dalam_masa_kehamilan(2)

    10/30

    .

    - semipermeable barrier

    - s te o meta o sm

    2. Drugs enter the fetal circulation

  • 8/6/2019 rps138_slide_obat-obat_dalam_masa_kehamilan(2)

    11/30

    PharmacodynamicsA. Maternal Drug Actions

    - e e ec s o rugs on repro uc ve ssuesof the pregnant woman sometimes are alteredby endocrine environment appropriate for thestage o t e pregnancy.

    - Drug effects on other system tissue (heart,significantly, though sometimes cardiac outputor renal blood flow maybe altered

    .insulin for pregnancy induced diabetic

  • 8/6/2019 rps138_slide_obat-obat_dalam_masa_kehamilan(2)

    12/30

    PharmacodynamicsB. Therapeutic Drug Actions in The Fetus

    - Drugs are given to the mother with thefetus as the target of the drug

    Examples:

    maturation when preterm birth is expected.

    jaundice

  • 8/6/2019 rps138_slide_obat-obat_dalam_masa_kehamilan(2)

    13/30

    .

    - chronic used of opioid by mothers drug

    - ACE-I used by the mothers renalamage n e e us

    - diethylstilbesterol adenocarcinoma

  • 8/6/2019 rps138_slide_obat-obat_dalam_masa_kehamilan(2)

    14/30

    Pharmacod namicsD. Teratogenicity

    Teratos = monster

    malformed baby

    Teratogen :* result in a characteristic set of malformation

    * exerts its effect at a particular stage of fetal

    eve opment organogenes s* show a dose-dependence incidence

  • 8/6/2019 rps138_slide_obat-obat_dalam_masa_kehamilan(2)

    15/30

    Teratogenic Action of Drugs influenced by :

    Dose

    requency

    Length of exposure Stage of pregnancy upon exposure

  • 8/6/2019 rps138_slide_obat-obat_dalam_masa_kehamilan(2)

    16/30

    Schematic Diagram of Critical Periods of Human

    Development

    Prenatal death Major morphologic abnormalitiesPhysiologic defect and minor

    morphologic abnormalities

  • 8/6/2019 rps138_slide_obat-obat_dalam_masa_kehamilan(2)

    17/30

    Poorl understood

    Probably multifactorial :- maternal tissue

    - differentiation process in the fetal tissue

    * vit. A (retinol)- deficiency of critical substance

    * folic acid deff. spina bifida

    - chronic consumption of high dose of ethanol fetal alcohol syndrome

  • 8/6/2019 rps138_slide_obat-obat_dalam_masa_kehamilan(2)

    18/30

    Pregnancy Safety Index (US FDA)ategory :

    - controlled studies in women (+)- fail to demonstrate a risk to the fetus in 1st semesterand later

    Category B:- -* no foetal risk, but no controlled studies in pregnant

    womens own an a verse e ec , u no con rme n con ro e

    studies in women in 1st semester or later

    Category C:

    - studies in animal revealed adverse effect (teratogenic orembryogenic or other)- no controlled studies in women

    Drugs should be given only if the potential benefit justifies

    the potential risk to the fetus

  • 8/6/2019 rps138_slide_obat-obat_dalam_masa_kehamilan(2)

    19/30

    Pr n n f In x FDA

    - there is positive evidence of human foetal risk, but thebenefits for the pregnant women may be acceptable (if the

    Cate or X:- studies in animal and human being foetal abnormalities- evidence of foetal risk based on human experience

    -outweights any possible benefit The drug is contraindicated in women who are or may

  • 8/6/2019 rps138_slide_obat-obat_dalam_masa_kehamilan(2)

    20/30

    Dru s to avoid in Pre nancPregnancy risk Description of Drugs to avoid

    Unsafe

    Acitretin, clomiphene,cocaine, ergots, ethanol,

    XAbsolutely

    contraindicated

    HMG-CoA reductaseinhibitors, isotretinoin,

    misoprostol, nicotin,premarin, quinine,

    raloxifen, thalidomide

    DEvidence of risk, but incertain circumtances,

    ACE-I, angiotensinantagonist (2nd and 3rd

    semesters),

    use maybe justifiable am nog ycos es

  • 8/6/2019 rps138_slide_obat-obat_dalam_masa_kehamilan(2)

    21/30

    st

    Teratogen

  • 8/6/2019 rps138_slide_obat-obat_dalam_masa_kehamilan(2)

    22/30

    Drug Effect Prenatal diagnosis

    um ar ac e ec s

    (Ebstein complex)

    eas e

    Warfarin Chondrodysplasia punctata Unlikely

    Facial anomalies

    Severe anomalies of CNS

    Unlikely

    Unlikely

    Phenytoin Craniofacial Feasible

    Limb

    Growth deficiency

    Feasible

    Feasible

    Sodium valproate CNS Feasible

    Carbamazepine Craniofacial

    Fingernail

    Feasible

    Feasible

    Sex hormone Cardiac defectsMultiple anomalies

    FeasibleFeasible

    Retinoic acids Craniofacial Feasible

    Cardiac

    CNS

    Feasible

    Feasible

  • 8/6/2019 rps138_slide_obat-obat_dalam_masa_kehamilan(2)

    23/30

    Drugs Given After The 1st Trimester

    ,

    moves from structural to physiologice ec s

    Sometimes adverse effects occur in

    the mother

  • 8/6/2019 rps138_slide_obat-obat_dalam_masa_kehamilan(2)

    24/30

    1. He arin : threatens mother rather than the fetus

    - unfractionated heparin given to pregnantwomen 20.000 unit/day for 3 months

    os eoporos s rac ure ver e rae

    - risk is less with low-molecular-weight

    2. Warfarin : damage the fetus, by causing bleeding into the

    fetal brain, eventhough the mothers anticoagulant

    control is good

  • 8/6/2019 rps138_slide_obat-obat_dalam_masa_kehamilan(2)

    25/30

    Antibiotic and Pregnancy

    Considered safe Maybe safe, can be used in certain

    circumstances

    Should be avoided

    Pnc G Trimethoprim/fetal abnormalities at 1st

    Tm folate antagonist

    Chloramphenicol

    Pnc V Tetracycline

    Ampicillin Aminoglycoside

    Amoxycilline SulfonamideErythromycin Erythromycin estolate (cholestasis) Metronidazole

    Floxacillin Ciprofloxacin

    ep a ospor n a om eIsoniazid Rifampicinhemorrhagic disease :

    give vit. K

    Ethambutol

  • 8/6/2019 rps138_slide_obat-obat_dalam_masa_kehamilan(2)

    26/30

    Antibiotic and Pregnancy

    Chloramphenicol Not teratogenic but gray baby

    Tetracycline Tooth discoloration, enamelhypoplasia, bone hypoplasia and

    Aminoglycoside Fetal citotoxicity

    u onam e ven c ose to e very ern-icterus and hemolytic anaemia

    Ciprofloxacin Fetal cartilage damage

    Thalidomide For leprosy phocomelia

  • 8/6/2019 rps138_slide_obat-obat_dalam_masa_kehamilan(2)

    27/30

  • 8/6/2019 rps138_slide_obat-obat_dalam_masa_kehamilan(2)

    28/30

    Use paracetamol

    Indomethacin could close the ductus

    arteriosus rematurel

  • 8/6/2019 rps138_slide_obat-obat_dalam_masa_kehamilan(2)

    29/30

    Cancer Chemotherapy During Pregnancy

    1. 1st trimester :-

    teratogens- the risk for malformation 10% for singleagen an or com na on

    2. Second and trimester :

    -teratogenesis, but could have non teratogeniceffects

    x. : owBrain development disturbances

  • 8/6/2019 rps138_slide_obat-obat_dalam_masa_kehamilan(2)

    30/30